BioCentury | Sep 14, 2018
Financial News

OncoResponse to move into clinic with $40M series B

...Alexandria Venture Investments, Arch Venture Partners, HT Family Office, Canaan Partners, Helsinn Investment Fund and William Marsh Rice University...
BioCentury | Sep 11, 2018
Financial News

OncoResponse to move into clinic with $40M series B

...Alexandria Venture Investments, Arch Venture Partners, HT Family Office, Canaan Partners, Helsinn Investment Fund and William Marsh Rice University...
BioCentury | Aug 8, 2016
Emerging Company Profile

Interrogating immunity

...Inc. , Canaan Partners , Theraclone Sciences Inc., University of Texas MD Anderson Cancer Center, William Marsh Rice University...
BioCentury | Oct 12, 2015
Financial News

OncoResponse completes venture financing

...million Investors: Arch Development; Canaan Partners; The University of Texas MD Anderson Cancer Center ; William Marsh Rice University...
Items per page:
1 - 4 of 4
BioCentury | Sep 14, 2018
Financial News

OncoResponse to move into clinic with $40M series B

...Alexandria Venture Investments, Arch Venture Partners, HT Family Office, Canaan Partners, Helsinn Investment Fund and William Marsh Rice University...
BioCentury | Sep 11, 2018
Financial News

OncoResponse to move into clinic with $40M series B

...Alexandria Venture Investments, Arch Venture Partners, HT Family Office, Canaan Partners, Helsinn Investment Fund and William Marsh Rice University...
BioCentury | Aug 8, 2016
Emerging Company Profile

Interrogating immunity

...Inc. , Canaan Partners , Theraclone Sciences Inc., University of Texas MD Anderson Cancer Center, William Marsh Rice University...
BioCentury | Oct 12, 2015
Financial News

OncoResponse completes venture financing

...million Investors: Arch Development; Canaan Partners; The University of Texas MD Anderson Cancer Center ; William Marsh Rice University...
Items per page:
1 - 4 of 4